Erratum: PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma (Science Translational Medicine DOI: 10.1016/j.bbcan.2016.06.002)

  • X. Tan
  • , P. Banerjee
  • , A. Pha E
  • , F. U.N. Rutaganira
  • , K. Basu
  • , N. Bota-Rabassedas
  • , H. F. Guo
  • , C. L. Grzeskowiak
  • , X. Liu
  • , J. Yu
  • , L. Shi
  • , D. H. Peng
  • , B. L. Rodriguez
  • , J. Zhang
  • , V. Zheng
  • , D. Y. Duose
  • , L. M. Solis
  • , B. Mino
  • , M. G. Raso
  • , C. Behrens
    • I. I. Wistuba, K. L. Scott, M. Smith, K. Nguyen, G. Lam, I. Choong, A. Mazumdar, J. L. Hill, D. L. Gibbons, P. H. Brown, W. K. Russell, K. Shokat, C. J. Creighton, J. S. Glenn, J. M. Kurie

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma (Science Translational Medicine DOI: 10.1016/j.bbcan.2016.06.002)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science